Price T Rowe Associates Inc Kymera Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,870,333 shares of KYMR stock, worth $232 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,870,333

Previous 6,645,474 3.38%

Holding current value

$232 Million

Previous $315 Million 12.12%

% of portfolio

0.03%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$39.06 - $51.84 $8.78 Million - $11.7 Million	224,859 Added 3.38%	6,870,333 $276 Million
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $7.69 Million - $13.4 Million	254,816 Added 3.99%	6,645,474 $315 Million
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $1.75 Million - $2.31 Million	58,646 Added 0.93%	6,390,658 $191 Million
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $22.8 Million - $43.4 Million	996,300 Added 18.67%	6,332,012 $255 Million
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $3.05 Million - $7.47 Million	278,287 Added 5.5%	5,335,712 $136 Million
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $698,850 - $1.2 Million	50,277 Added 1.0%	5,057,425 $70.3 Million
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $7.63 Million - $11.9 Million	340,467 Added 7.3%	5,007,148 $115 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $7.14 Million - $11.1 Million	287,522 Added 6.57%	4,666,681 $138 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $5.51 Million - $8.7 Million	281,447 Added 6.87%	4,379,159 $109 Million
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $23.6 Million - $38.6 Million	-1,126,974 Reduced 21.57%	4,097,712 $89.2 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $18.8 Million - $56.6 Million	1,329,481 Added 34.13%	5,224,686 $103 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $12.2 Million - $22.3 Million	344,677 Added 9.71%	3,895,205 $165 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $15.8 Million - $20.8 Million	317,331 Added 9.81%	3,550,528 $225 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $66.4 Million - $92.5 Million	1,388,271 Added 75.25%	3,233,197 $190 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $28.3 Million - $47.4 Million	911,948 Added 97.75%	1,844,926 $89.5 Million
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $19.3 Million - $46.2 Million	540,902 Added 137.96%	932,978 $36.3 Million
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $11 Million - $34.4 Million	392,076 New	392,076 $24.3 Million

Others Institutions Holding KYMR

# of Institutions

185

Shares Held

60.3M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.84B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Kymera Therapeutics, Inc. Transaction History